1. Home
  2. SRPT vs SLVM Comparison

SRPT vs SLVM Comparison

Compare SRPT & SLVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • SLVM
  • Stock Information
  • Founded
  • SRPT 1980
  • SLVM 1898
  • Country
  • SRPT United States
  • SLVM United States
  • Employees
  • SRPT N/A
  • SLVM N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • SLVM Paper
  • Sector
  • SRPT Health Care
  • SLVM Basic Materials
  • Exchange
  • SRPT Nasdaq
  • SLVM Nasdaq
  • Market Cap
  • SRPT 2.0B
  • SLVM 1.8B
  • IPO Year
  • SRPT 1997
  • SLVM N/A
  • Fundamental
  • Price
  • SRPT $18.52
  • SLVM $45.29
  • Analyst Decision
  • SRPT Hold
  • SLVM Hold
  • Analyst Count
  • SRPT 31
  • SLVM 3
  • Target Price
  • SRPT $40.61
  • SLVM $75.00
  • AVG Volume (30 Days)
  • SRPT 7.8M
  • SLVM 404.9K
  • Earning Date
  • SRPT 11-05-2025
  • SLVM 11-11-2025
  • Dividend Yield
  • SRPT N/A
  • SLVM 3.96%
  • EPS Growth
  • SRPT N/A
  • SLVM N/A
  • EPS
  • SRPT N/A
  • SLVM 5.23
  • Revenue
  • SRPT $2,481,531,000.00
  • SLVM $3,550,000,000.00
  • Revenue This Year
  • SRPT $10.78
  • SLVM N/A
  • Revenue Next Year
  • SRPT N/A
  • SLVM $1.97
  • P/E Ratio
  • SRPT N/A
  • SLVM $8.69
  • Revenue Growth
  • SRPT 64.89
  • SLVM N/A
  • 52 Week Low
  • SRPT $10.42
  • SLVM $37.52
  • 52 Week High
  • SRPT $138.81
  • SLVM $98.02
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 51.43
  • SLVM 51.30
  • Support Level
  • SRPT $17.05
  • SLVM $43.93
  • Resistance Level
  • SRPT $18.84
  • SLVM $46.75
  • Average True Range (ATR)
  • SRPT 1.02
  • SLVM 1.37
  • MACD
  • SRPT -0.01
  • SLVM 0.23
  • Stochastic Oscillator
  • SRPT 60.51
  • SLVM 64.36

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About SLVM Sylvamo Corporation

Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.

Share on Social Networks: